Nabriva Therapeutics (NBRVF) Q2 2019 Earnings

8AugExpected
Q3 2018
Q4 2018
Q1 2019
Q2 2019
-0.9
-0.7
-0.49
-0.29

Details

Expected EPS
-0.34
Actual EPS
-0.3
Surprise EPS
0.04
Surprise Percent
+11.76%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.3 per share for Q2 2019.

0 Comments

Share your thoughts